Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

14 Mar 2024 07:13

RNS Number : 8433G
Compagnie de Saint-Gobain
14 March 2024
 

SAINT-GOBAIN accelerateS in construction chemicals and supports the development of BREAKTHROUGH DECARBONIZATION TECHNOLOGIES

 

Saint-Gobain Construction Chemicals is expanding its efforts to deploy new additives for low-carbon cement and concrete. These low-carbon technologies open up tremendous opportunities for co-development with new partners in fast-growing markets and to accelerate Saint-Gobain's profitable growth in construction chemicals.

 

Two partnerships illustrate this move:

- Saint-Gobain has participated in the fund raising of Fortera, a start-up that has developed a process for making low-carbon cement by recycling CO2 emitted during production. Cement production currently accounts for around 8% of the world's annual CO2 emissions. By investing in Fortera, through NOVA, its venture capital activity, Saint-Gobain is supporting cutting-edge technologies that curb CO2 at source. Founded in 2019, Fortera has developed a groundbreaking technology that integrates with existing cement plants, leveraging their limestone resources. Through the patented ReCarb? process, Fortera is able to mineralize CO2, reducing direct carbon emissions of existing cement plants by 70%. This paves the way to net zero carbon cement production (scope 1 and 2) when the process is combined with green energy sources.

 

- As a shareholder, the Group also supports Ecocem, European leader in low-carbon cement technologies, in its development and marketing of new cement technologies for large-scale application. Its groundbreaking ACT technology, compatible with all supplementary cementitious materials (SCMs) has just obtained a European Technical Assessment. Based on published environmental product declarations, the carbon footprint of the ACT product has been assessed to be 70% lower than the carbon footprint* of an average CEM II cement sold within the European market.

 

These developments are in line with Saint-Gobain's "Grow & Impact" strategy aiming to both strengthen the Group's leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

 

* Life Cycle Assessment (LCA) indicator "total Global Warming Potential" (GWP) assessed from cradle to gate - based on the following published 3rd party verified Environmental Product Declarations (EPD): https://cembureau.eu/media/f2ubx2lk/epd-for-cement-cem-ii.pdf; https://www.mrpi.nl/epd-files/epd/1.1.00486.2023_MRPI-EPD_ACT%201%20_FINAL.pdf

 

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose, "MAKING THE WORLD A BETTER HOME".

 

?47.9 billion in sales in 2023

160,000 employees, locations in 76 countries

Committed to achieving net zero carbon emissions by 2050

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQJIMRTMTMBMPI
Date   Source Headline
18th May 20068:17 amRNSIssue of Debt
27th Apr 20065:14 pmRNS1st Quarter Results
27th Apr 20065:09 pmRNSDisposal
27th Mar 20066:30 pmRNSPublication of Prospectus
24th Mar 20069:25 amRNSFinal Results
2nd Feb 20068:22 amRNSFinal Results
8th Dec 20051:08 pmRNSCompulsory Acqn of Shares
17th Nov 20057:02 amRNSOffer for BPB plc
14th Nov 20057:30 amRNSOffer Update
9th Nov 20053:29 pmRNSOffer Update
31st Oct 20057:36 amRNSOffer Update
26th Oct 20054:59 pmRNSAcquisition
25th Oct 20055:24 pmRNS3rd Quarter Results
5th Oct 20055:08 pmRNSResponse to BPB's statement
5th Oct 20058:10 amRNS600m return, dividends up
5th Oct 20057:58 amRNSBPB: Offer Timetable Extended
3rd Oct 200510:12 amRNSLow level of acceptances
3rd Oct 20057:30 amRNSOffer Update
20th Sep 20055:13 pmRNSAcquisition
15th Sep 20052:14 pmRNSResponse to Saint-Gobain
14th Sep 20054:00 pmRNSResponse to BPB Document
31st Aug 20059:28 amRNSResponse to St Gobain offer
31st Aug 20058:35 amRNSOffer Document Posted
3rd Aug 20051:04 pmRNSResponse to St-Gobain offer
3rd Aug 200512:13 pmRNSOffer for BPB PLC
3rd Aug 20057:20 amRNSRejects unsolicited proposal
29th Jul 20057:02 amRNSInterim Results
29th Jul 20057:01 amRNSInterim Results
22nd Jul 20055:00 pmRNSResponse to BPB plc Statement
22nd Jul 200512:34 pmRNSStmnt re BPB PLC - Addendum
21st Jul 20052:22 pmRNSStatement re BPB PLC
30th Jun 20055:05 pmRNSDisposal
21st Jun 20057:51 amRNSAcquisition
9th Jun 20056:13 pmRNSAGM Statement
26th May 20058:11 amRNSDisposal
4th May 20055:12 pmRNSAppointments
4th May 20058:02 amRNSAppointment
4th May 20057:55 amRNSAcquisition
26th Apr 20056:00 pmRNS1st Quarter Results
19th Apr 20059:34 amRNSRe Joint Venture
7th Apr 20057:46 amRNSAcquisition
24th Mar 20056:35 pmRNSFinal Results
24th Feb 20059:34 amRNSStatement re Investigation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.